Countries Restrict AstraZeneca Vaccine for Younger Adults
Amid concerns over clotting risks, German and Canadian health officials have restricted usage of the AstraZeneca COVID-19 vaccine in people under the age of...
AstraZeneca COVID-19 Vaccine Data Highlight Safety Monitoring Boards’ Role in Clinical Trials
Confusion over AstraZeneca’s COVID-19 vaccine trial data recently arose when the data and safety monitoring boards (DSMBs) overseeing the trial took a public stand...
How Do Patients With Myeloproliferative Neoplasms Fare After COVID-19 Infection?
Two analyses from the MPN-COVID study from a group of researchers led by Tiziano Barbui, MD, of the United Hospitals of Bergamo in Italy,...
Reader Responses: How long should a young patient with COVID-19 and pulmonary embolism receive...
Here’s how readers responded to a You Make the Call question about anticoagulation for a young patient with COVID-19 and pulmonary embolism.
Disclaimer: ASH does...
You Make the Call: How long should a young patient with COVID-19 and pulmonary...
This month, Caroline Berube, MD, discusses anticoagulation for a young patient with COVID-19 and pulmonary embolism.
And don't forget to check out next month's clinical...
The Long Haul
For some people infected with COVID-19, the disease does not end with the swift resolution of all symptoms.
Last year, Sudipto Mukherjee, MD, MPH, a...
Benefits of AstraZeneca’s COVID-19 Vaccine Outweigh Clotting Risk, Regulatory Agencies Say
Following reports of an unusual increase in cerebral sinus venous blood clots and one death associated with the COVID-19 vaccine developed by AstraZeneca and...
Older Age, Pre-Existing Comorbidities Increase Poor Outcomes in Patients With SCD and COVID-19
Patients with sickle cell disease (SCD) have poor outcomes associated with COVID-19, particularly if they are older or present with end organ damage, acute...
Adults With Hematologic Malignancies and COVID-19 Fare Worse Than Children
Adults with hematologic malignancies and COVID-19 infection have a substantially higher risk of death compared with children with hematologic malignancies and COVID-19, according to...
FDA Issues Guidance for Measuring Viscoelasticity Amid COVID-19 Pandemic
The FDA has issued immediate guidance for expanding the availability and capability of coagulation systems for measuring whole blood viscoelastic properties to assess hemostasis....
Current Issue
April 2021 Volume 7 Issue 5
This issue examines long-haul COVID-19, central nervous system relapse in non-Hodgkin lymphoma, and more.